[go: up one dir, main page]

CA2363119A1 - Hemocompatible surfaces and method for producing same - Google Patents

Hemocompatible surfaces and method for producing same Download PDF

Info

Publication number
CA2363119A1
CA2363119A1 CA002363119A CA2363119A CA2363119A1 CA 2363119 A1 CA2363119 A1 CA 2363119A1 CA 002363119 A CA002363119 A CA 002363119A CA 2363119 A CA2363119 A CA 2363119A CA 2363119 A1 CA2363119 A1 CA 2363119A1
Authority
CA
Canada
Prior art keywords
hemocompatible
producing same
hemocompatible surfaces
present
fields
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002363119A
Other languages
French (fr)
Other versions
CA2363119C (en
Inventor
Michael Hoffmann
Roland Horres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2363119A1 publication Critical patent/CA2363119A1/en
Application granted granted Critical
Publication of CA2363119C publication Critical patent/CA2363119C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
    • A61L33/128—Other specific proteins or polypeptides not covered by A61L33/122 - A61L33/126
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/18—Use of ingredients of undetermined constitution or reaction products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention concerns hemocompatible surfaces characterized in that they contain materials, and constituents of the outer layers of blood cells and/or mesothelial cells are applied and/or incorporated onto and/or into the surfaces of said materials. The present invention further concerns a process for making hemocompatible surfaces and their use in extensive fields of health, in medicine, dentistry, surgery, cosmetics or in fields having contact with blood, tissue and/or other body fluids.
CA002363119A 1999-02-26 2000-02-24 Hemocompatible surfaces and method for producing same Expired - Fee Related CA2363119C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19908318.5 1999-02-26
DE19908318A DE19908318A1 (en) 1999-02-26 1999-02-26 Hemocompatible surfaces and methods of making them
PCT/EP2000/001497 WO2000050106A2 (en) 1999-02-26 2000-02-24 Hemocompatible surfaces and method for producing same

Publications (2)

Publication Number Publication Date
CA2363119A1 true CA2363119A1 (en) 2000-08-31
CA2363119C CA2363119C (en) 2007-04-10

Family

ID=7898933

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002363119A Expired - Fee Related CA2363119C (en) 1999-02-26 2000-02-24 Hemocompatible surfaces and method for producing same

Country Status (12)

Country Link
EP (1) EP1152778B1 (en)
JP (1) JP3597474B2 (en)
KR (1) KR100503913B1 (en)
CN (1) CN1198660C (en)
AT (1) ATE250437T1 (en)
AU (1) AU758873B2 (en)
BR (1) BR0008968A (en)
CA (1) CA2363119C (en)
DE (2) DE19908318A1 (en)
IL (1) IL144912A (en)
WO (1) WO2000050106A2 (en)
ZA (1) ZA200106738B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8679520B2 (en) 2001-10-15 2014-03-25 Hemoteq Ag Coating of stents for preventing restenosis
US8784862B2 (en) 2002-05-09 2014-07-22 Hemoteq Ag Compounds and method for coating surfaces in a hemocompatible manner
US10080821B2 (en) 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US10369256B2 (en) 2009-07-10 2019-08-06 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10329296B4 (en) * 2003-06-24 2007-07-12 Leibniz-Institut Für Polymerforschung Dresden E.V. Coating system for biomaterials
DE102005040211B4 (en) 2005-08-16 2010-02-11 Maquet Cardiopulmonary Ag Use of nonionic esters in a coating for blood contacting surfaces and medical device
BRPI0722412B8 (en) 2006-07-03 2021-06-22 Hemoteq Ag use of a composition consisting of rapamycin or rapamycin and paclitaxel and balloon catheter
KR20120106880A (en) 2007-01-21 2012-09-26 헤모텍 아게 Medical product for treating stenosis of body passages and for preventing threatening restenosis
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
EP2611476B1 (en) 2010-09-02 2016-08-10 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US8669360B2 (en) 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
CN102501344B (en) * 2011-09-29 2014-07-16 华东交通大学 Method for constructing hemocompatible material surface with bionic periodic structure
KR20180074818A (en) 2013-02-08 2018-07-03 아셀, 인크. Methods of manufacturing bioactive gels from extracellular matrix material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350629A (en) * 1981-07-29 1982-09-21 Massachusetts Institute Of Technology Procedures for preparing composite materials from collagen and glycosaminoglycan
DE3639561A1 (en) * 1986-11-20 1988-06-01 Baumann Hanno METHOD FOR PRODUCING NON-THROMBOGEN SUBSTRATES
US5236835A (en) * 1988-10-05 1993-08-17 Hapgood, C.V. Electro insertion of proteins into red cell membranes
US5043164A (en) * 1989-01-17 1991-08-27 The University Of Tennessee Research Corporation Blood-stable, cholesterol-free liposomes
GB9116036D0 (en) * 1991-07-25 1991-09-11 Univ Leicester Preparing grafts for implantation
DE4402064A1 (en) * 1994-01-25 1995-07-27 Kohlensaeurewerk Deutschland Process for controlling pests in bulk material
US5643712A (en) * 1994-05-20 1997-07-01 Brasile; Lauren Method for treating and rendering grafts nonthrombogenic and substantially nonimmunogenic using an extracellular matrix coating
DE19505070C2 (en) * 1995-02-15 1997-03-27 Axel Prof Dr Med Haverich Artificial vascular systems and processes for their manufacture
DE19648876C2 (en) * 1996-11-16 1999-10-07 Will Minuth Method of making a natural implant
DE19700078A1 (en) * 1997-01-03 1998-07-09 Huels Chemische Werke Ag Production of polymeric materials with cell proliferation-promoting properties
DE19706667A1 (en) * 1997-02-20 1998-08-27 Merck Patent Gmbh Bone replacement material with a surface covering with peptides with RGD amino acid sequence
DE19724869C2 (en) * 1997-06-12 1999-05-12 Henkel Kgaa Use of citosan derivatives for surface coating

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8679520B2 (en) 2001-10-15 2014-03-25 Hemoteq Ag Coating of stents for preventing restenosis
US8784862B2 (en) 2002-05-09 2014-07-22 Hemoteq Ag Compounds and method for coating surfaces in a hemocompatible manner
US10369256B2 (en) 2009-07-10 2019-08-06 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon
US11278648B2 (en) 2009-07-10 2022-03-22 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon
US10080821B2 (en) 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density

Also Published As

Publication number Publication date
WO2000050106A2 (en) 2000-08-31
BR0008968A (en) 2001-11-27
IL144912A0 (en) 2002-06-30
AU758873B2 (en) 2003-04-03
CN1341033A (en) 2002-03-20
ATE250437T1 (en) 2003-10-15
AU4287100A (en) 2000-09-14
EP1152778A1 (en) 2001-11-14
KR20010104343A (en) 2001-11-24
JP2002537075A (en) 2002-11-05
WO2000050106A3 (en) 2001-04-26
DE50003828D1 (en) 2003-10-30
KR100503913B1 (en) 2005-07-26
IL144912A (en) 2009-09-22
CA2363119C (en) 2007-04-10
EP1152778B1 (en) 2003-09-24
CN1198660C (en) 2005-04-27
JP3597474B2 (en) 2004-12-08
ZA200106738B (en) 2002-08-15
DE19908318A1 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
CA2363119A1 (en) Hemocompatible surfaces and method for producing same
CA2140090A1 (en) Composite bioabsorbable materials and surgical articles made therefrom
AU775126C (en) Substituted oxazolidinones and their use in the field of blood coagulation
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
CA2173316A1 (en) Local polymeric gel cellular therapy
CA2340251A1 (en) Insertable stent and methods of making and using same
WO2003087254A3 (en) Hydrophilic adhesive compositions__________________________
FR2721198B1 (en) Flexible implantable prosthesis, used in surgery for volume increase or soft tissue reconstruction, in particular breast prosthesis.
PL321781A1 (en) Method of coating objects with hialuronic acid, its derivatives and semi-synthetic polymers
AU2002220577A1 (en) Circulatory device for separating substances in bodily fluids, especially blood,and the use of said device
CA2212058A1 (en) Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease
CA2350713A1 (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
ZA977494B (en) Phenyl-substituted alkenylcarboxylic acid guanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
FI971951L (en) 2,2-Dichloroalkanecarboxylic acids, methods for their preparation, medicaments containing them, and their use for the treatment of insulin resistance
WO2002040069A3 (en) Bioactive surgical suture
AU2001250978A1 (en) Polynucleotides and polypeptides, their use in diagnosis and treatment of cardiac, renal or inflammary disease
EE200300504A (en) Preparations of 3,7-diazabicyclo [3.3.1], methods for their preparation and their use in the prophylaxis or treatment of cardiac arrhythmias
AU3382089A (en) Uncrosslinked hydrogel, process for its preparation and its uses as an article for medical and/or surgical purposes such as tubes, filaments, films, joints, implants and the like, particularly in ophthalmology
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
EP0263552A3 (en) Composite material for medical or paramedical, particularly orthopaedic use and method for manufacturing it
EE200300495A (en) Preparations of 3,7-diazabicyclo [3.3.1], methods for their preparation and their use in the prophylaxis or treatment of cardiac arrhythmias
CA2376033A1 (en) Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy
WO2002085325A3 (en) Production and use of a suspension composition comprising an ultrasound contrast medium
PL1626750T3 (en) Biocompatible polymer
FR2717069B1 (en) A medical prosthesis, such as a blood filter, provided with a coating limiting adhesion or cell development.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed